Skip to content

Clinical trials

Completed Inflammatory Bowel Diseases trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Status: Completed Country / region: Serbia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20114
20121
20151
20161
20171
20181
20201
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC4
Eli Lilly and Company1
InDex Pharmaceuticals1
Kyowa Kirin, Inc.1
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1
Pfizer1
Protagonist Therapeutics, Inc.1
Toray Industries, Inc1
University Medical Center Zvezdara1
Warner Chilcott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases13
Colitis, Ulcerative7
Colitis4
Crohn Disease4
Gastrointestinal Diseases2
Abdominal Pain1
Autoimmune Diseases1
Colonic Diseases1
Digestive System Diseases1
Intestinal Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.